OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
March 02, 2014
Tablet Press with Fastest-in-Class Changeover
February 27, 2014
Discovery of split and broken tablets led to drug recalls.
February 26, 2014
Moody's Investor Service reports AbbVie, Amgen, and Roche are the most exposed to biosimilar competition.
February 11, 2014
EMA releases an update on its flu vaccine guidance.
February 07, 2014
Mylan Pharmaceuticals launches Hertraz, the world's first trastuzumab biosimilar in India.
February 05, 2014
BioOutsource will open a new Biosimilar Center of Excellence in Scotland.
February 02, 2014
PDA works with FDA to create pharmaceutical quality metrics.
CMOs may find opportunities in alternative expression services.
Experts discuss factors affecting drug delivery to the lungs and key considerations when developing inhalation formulations.
Automated sample handling, advanced glycan analysis, and specially designed columns are help speed up confirmation of the biosimilarity.